Remdesivir triphosphate as a potential repurposed drug against the emerging Bundibugyo Ebolavirus 2026

Journal of Infection · Published 2026-06-09 · DOI 10.1016/j.jinf.2026.106788

Free full text

Authors (17)

Mansi Dutt, Misaki Wayengera, Gustavo Sganzerla Martinez, Anuj Kumar, Andrew Nsawotebba, Isaac Ssewanya, Suzan Nabadda, Barnabas Bakamutumaho, Bruce Kirenga, Charles Olaro, Winters Muttamba, Pauline Byakika, Jane-Ruth O. Aceng, Diana Atwiine, Henry Kyobe Bosa, David Kelvin, Wilber Sabiiti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dutt, M., Wayengera, M., Martinez, G., et al. (2026). Remdesivir triphosphate as a potential repurposed drug against the emerging Bundibugyo Ebolavirus 2026. Journal of Infection. https://doi.org/10.1016/j.jinf.2026.106788

Related articles

• A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment · Journal of Infection · 2026 · Same journal
• Global surveillance reveals progressive erosion of benzylpenicillin susceptibility in Streptococcus suis · Journal of Infection · 2026 · Same journal
• Home-based rapid testing and early antiviral treatment as a potential strategy to blunt pediatric influenza peak · Journal of Infection · 2026 · Same journal
• Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infection · Journal of Infection · 2026 · Same journal
• Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990–2021: A systematic analysis of the global burden of disease study 2021 · Journal of Infection · 2026 · Same journal
• Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients · Journal of Infection · 2026 · Same journal
• Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England · Journal of Infection · 2026 · Same journal
• Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025 · Journal of Infection · 2026 · Same journal
• Within-host evolution of tandemly duplicated blaKPC-14 conferring cross-resistance to ceftazidime-avibactam, cefiderocol and aztreonam-avibactam in hypervirulent ST11 Klebsiella pneumoniae · Journal of Infection · 2026 · Same journal
• Respiratory viral detection in adult severe acute respiratory infection post-COVID-19 pandemic: implications for antimicrobial stewardship · Journal of Infection · 2026 · Same journal